Tiopronin 300 mg/1 (Tiopronin TABLET, DELAYED RELEASE) 300 mg/1

Tiopronin 300 mg is a delayed-release tablet used for managing certain medical conditions. This medication is designed to provide gradual relief and support overall health.

Strength

300 mg/1

Pack Size

90 TABLET, DELAYED RELEASE in 1 BOTTLE (0480-7824-98)

Manufacturer / TM Owner

Teva Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tiopronin is commonly used to manage conditions related to cystine stone formation and to support kidney health. It works by binding to cystine, preventing the formation of kidney stones. People often ask, 'What is Tiopronin used for?' and the answer typically involves its role in reducing cystine levels in the urine.

Side Effects

Tiopronin may cause common side effects such as nausea, vomiting, and rash. Some users might experience changes in taste or mild gastrointestinal discomfort. These effects are generally mild and temporary.

Precautions & Warnings

Tiopronin should be handled with care, especially for individuals with known allergies to the medication. It is important to follow the prescribed guidelines and consult a healthcare provider before starting any new medication.

Avoid Interactions

Tiopronin may interact with certain medications, including those metabolized by the liver. It is advisable to avoid alcohol while taking Tiopronin, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Tiopronin is primarily used to manage cystine stone formation and support kidney health by binding to cystine in the urine.

Tiopronin is typically taken orally as a delayed-release tablet. Follow the instructions provided by your healthcare provider.

Common side effects may include nausea, vomiting, rash, and changes in taste. These effects are usually mild and temporary.

Tiopronin may interact with certain medications, so it is important to consult your healthcare provider before combining it with other drugs.

The safety of long-term use of Tiopronin should be discussed with a healthcare provider, who can assess individual needs and risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.